China Resources Pharmaceutical Group Limited (HKG:3320)
4.500
-0.050 (-1.10%)
Jun 18, 2026, 4:08 PM HKT
HKG:3320 Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, HKG:3320 stock has a consensus rating of "Buy" and an average price target of $6.79. The average 1-year stock price forecast is 50.89% higher than the current stock price, while the lowest is $5.90 (+31.11%) and the highest is $7.52 (+67.11%).
Price Target: $6.79 (+50.89%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 20, 2026.
Analyst Ratings
The average analyst rating for HKG:3320 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $6.82 | Buy | Maintains | $6.82 | +51.56% | Apr 20, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $7.00 | Buy | Maintains | $7.00 | +55.56% | Mar 27, 2026 |
Unknown Analyst Nomura No rating | Nomura | Buy Maintains $7.52 | Buy | Maintains | $7.52 | +67.11% | Mar 27, 2026 |
Unknown Analyst China Merchants Securities No rating | China Merchants Securities | Buy Maintains $6.30 | Buy | Maintains | $6.30 | +40.00% | Mar 26, 2026 |
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Buy Maintains $5.90 | Buy | Maintains | $5.90 | +31.11% | Mar 25, 2026 |
Financial Forecast
Revenue This Year
285.94B
from 269.57B
Increased by 6.07%
Revenue Next Year
300.59B
from 285.94B
Increased by 5.12%
EPS This Year
0.69
from 0.64
Increased by 7.90%
EPS Next Year
0.74
from 0.69
Increased by 7.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 294.2B | ||
| Avg | 285.9B | ||
| Low | 282.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.1% | ||
| Avg | 6.1% | ||
| Low | 4.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.69 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 7.9% | ||
| Low | - |